| Company type | listed | ||||||
|---|---|---|---|---|---|---|---|
| |||||||
| Industry | Pharmaceutical | ||||||
| Founded | 2000 | ||||||
| Headquarters | , | ||||||
Area served | People's Republic of China | ||||||
Key people | Executive chairwoman: Ms. Theresa Tse CEO: Mr. Yi Li[1][2] | ||||||
| Parent | Charoen Pokphand Group[citation needed] | ||||||
| Chinese name | |||||||
| Simplified Chinese | 中国生物制药有限公司 | ||||||
| Traditional Chinese | 中國生物製藥有限公司 | ||||||
| |||||||
| Chinese short name | |||||||
| Simplified Chinese | 中生制药 | ||||||
| Traditional Chinese | 中生製藥 | ||||||
| |||||||
| second alternative short name | |||||||
| Simplified Chinese | 中国生物制药 | ||||||
| Traditional Chinese | 中國生物製藥 | ||||||
| |||||||
| Website | Sino Biopharmaceutical Limited | ||||||
Sino Biopharmaceutical Limited (SEHK: 1177|Hang Seng Index component) (simplified Chinese: 中国生物制药有限公司; traditional Chinese: 中國生物製藥有限公司; pinyin: zhōng guó shēng wù zhì yào yǒu xiàn gōng sī), shortly Sino Biopharm, is a civilian-run enterprise principally engaged in the medicine products business in Mainland China.
Being a member of Charoen Pokphand Group[citation needed] and headquartered in Hong Kong and Beijing, Sino Biopharm is engaged in researching, developing, producing, and selling biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis through its subsidiaries.[3]
Sino Biopharm is also involved in other minor businesses through its subsidiaries, such as properties, health food, optical glass, optical and auditory products.[4]
YouTube Encyclopedic
-
1/3Views:2 4559791 624
-
中國生物製藥 1177目標倍升？
-
BEST PENNY STOCK TO BUY NOW | Top Penny Stock to buy now | Huge Upside potential [Blrx Stock]
-
Novocure (NVCR) - Stock Analysis! 10x UPSIDE? ANOTHER LVGO?
Transcription
References
- ^
"Sino Biopharmaceutical Limited: Profile". Retrieved 2021-05-26.
Ms. Y. Y. Tse - Exec. Chairman... Mr. Yi Li - CEO & Exec. Director
- ^ "Sino Biopharmaceutical Limited 1177.HK: People". Reuters. Retrieved 2021-05-26.
Y. Y. Tse - 26 - Executive Chairwoman of the Board, Yi Li - 59 - Chief Executive Officer, Executive Director
- ^ "Sino Biopharmaceutical | Company Overview & News". Forbes. Archived from the original on 2023-05-23.
- ^ About the company
External links
- Business data for Sino Biopharmaceutical Limited:
- Sino Biopharmaceutical Limited
 | This Chinese corporation or company article is a stub. You can help Wikipedia by expanding it. |
This page was last edited on 30 July 2023, at 17:40